US 8691828
Thienopyrimidine as CDC7 kinase inhibitors
granted A61PA61P35/00A61P35/02
Quick answer
US patent 8691828 (Thienopyrimidine as CDC7 kinase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P35/04, A61P43/00